Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K S Iwamoto

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Radiation Research|July 1, 1994
Production of 13-hydroxyoctadecadienoic acid and tumor necrosis factor-alpha by murine peritoneal macrophages in response to irradiationK S Iwamoto, W H McBride
Investigative Radiology|November 1, 1991
Iodinated contrast agents for brain tumor localization and radiation dose enhancementA Norman, K S Iwamoto, S T Cochran
Physics in Medicine and Biology|February 1, 1992
Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumoursT D Solberg, K S Iwamoto, A Norman
Mutation Research|May 1, 1988
A sensitive assay for 6-thioguanine-resistant lymphocytesA Norman, J C Mitchell, K S Iwamoto
Molecular Carcinogenesis|June 12, 1999
Mutant p53: epigenetic mutator of the T-cell receptor via induction of methylationK S Iwamoto, T Mizuno, T Seyama, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1992
Radiation sensitive breast cancer patientsA Norman, K S Iwamoto, A R Kagan, et al.
Journal of the National Cancer Institute|August 13, 1998
Frequency of p53 mutations in hepatocellular carcinomas from atomic bomb survivorsK S Iwamoto, T Mizuno, S Tokuoka, et al.
Oncogene|October 23, 1997
Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesisT Mizuno, S Kyoizumi, T Suzuki, et al.
Nutrition and Cancer|January 1, 1988
Antitumor activity of sodium linoleateA Norman, L R Bennett, J F Mead, et al.
Human Pathology|May 1, 1998
Multiple, unique, and common p53 mutations in a thorotrast recipient with four primary cancersK S Iwamoto, T Mizuno, A Kurata, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Radiation Research|July 1, 1994
Production of 13-hydroxyoctadecadienoic acid and tumor necrosis factor-alpha by murine peritoneal macrophages in response to irradiationK S Iwamoto, W H McBride
Investigative Radiology|November 1, 1991
Iodinated contrast agents for brain tumor localization and radiation dose enhancementA Norman, K S Iwamoto, S T Cochran
Physics in Medicine and Biology|February 1, 1992
Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumoursT D Solberg, K S Iwamoto, A Norman
Mutation Research|May 1, 1988
A sensitive assay for 6-thioguanine-resistant lymphocytesA Norman, J C Mitchell, K S Iwamoto
Molecular Carcinogenesis|June 12, 1999
Mutant p53: epigenetic mutator of the T-cell receptor via induction of methylationK S Iwamoto, T Mizuno, T Seyama, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 1992
Radiation sensitive breast cancer patientsA Norman, K S Iwamoto, A R Kagan, et al.
Journal of the National Cancer Institute|August 13, 1998
Frequency of p53 mutations in hepatocellular carcinomas from atomic bomb survivorsK S Iwamoto, T Mizuno, S Tokuoka, et al.
Oncogene|October 23, 1997
Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesisT Mizuno, S Kyoizumi, T Suzuki, et al.
Nutrition and Cancer|January 1, 1988
Antitumor activity of sodium linoleateA Norman, L R Bennett, J F Mead, et al.
Human Pathology|May 1, 1998
Multiple, unique, and common p53 mutations in a thorotrast recipient with four primary cancersK S Iwamoto, T Mizuno, A Kurata, et al.
Pageof 3